--2024/Q4-- / 14.540M--
--2024/Q3-- / 10.801M--
Aug 14, 20242024/Q28.054M / 7.970M--
May 14, 20242024/Q16.102M / 5.977M--
Mar 13, 20242023/Q46.096M / 5.771M--
US Stock MarketDetailed Quotes
SCPH scPharmaceuticals
- 5.370
- +0.230+4.47%
Close Aug 23 16:00 ET
- 5.400
- +0.030+0.56%
Post 18:55 ET
268.65MMarket Cap-3442P/E (TTM)
5.450High5.065Low375.51KVolume5.150Open5.140Pre Close2.02MTurnover1.28%Turnover RatioLossP/E (Static)50.03MShares7.98052wk High29.03P/B158.19MFloat Cap3.24052wk Low--Dividend TTM29.46MShs Float18.170Historical High--Div YieldTTM7.49%Amplitude2.440Historical Low5.375Avg Price1Lot Size
scPharmaceuticals Key Stats
scPharmaceuticals Q2 2024 Earnings Date
Currency：USDAug 14, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 7.97M | 8.05M | +84.33K |
| Beat Est. | +386.55% | +391.70% | +1.06% |
| EPS | -0.42 | -0.44 | -0.02 |
| Miss Est. | -16.20% | -22.22% | -5.21% |
Analyst Rating
Aug 19, 2024
scPharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
scPharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg